Literature DB >> 11291558

The role of genetic factors in the etiology of pancreatic adenocarcinoma: an update.

P O Chappuis1, P Ghadirian, W D Foulkes.   

Abstract

Pancreatic cancer is a disease with a very poor prognosis and its etiology is still largely elusive. The only consistent environmental risk factor is cigarette smoking. A previous history of pancreatitis or diabetes mellitus is also considered to be a risk factor. Epidemiological studies have confirmed that relatives of those with pancreatic cancer have an increased risk of this malignancy, and it has been evaluated that 3-5% of all pancreatic cancer cases are caused by genetic predisposition to the disease. Usually this occurs in the setting of a known inherited cancer syndrome caused by mutations in genes such as BRCA1/2 and CDKN2A. Whether or not a true site-specific pancreatic adenocarcinoma syndrome exists is not known. The real challenge for the management of high risk patients is to develop new screening methods than can identify pre-neoplastic or early neoplastic lesions in a timely manner.

Entities:  

Mesh:

Year:  2001        PMID: 11291558     DOI: 10.1081/cnv-100000076

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  8 in total

1.  Risk of pancreatic adenocarcinoma in chronic pancreatitis.

Authors:  D Malka; P Hammel; F Maire; P Rufat; I Madeira; F Pessione; P Lévy; P Ruszniewski
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

2.  Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients.

Authors:  Hans-Olof Nilsson; Unne Stenram; Ingemar Ihse; Torkel Wadstrom
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

Review 3.  Familial pancreatic carcinoma in Jews.

Authors:  Henry T Lynch; Carolyn A Deters; Jane F Lynch; Randall E Brand
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 4.  Smoking-gene interaction and disease development: relevance to pancreatic cancer and atherosclerosis.

Authors:  Xing Li Wang; Jian Wang
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

5.  XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer.

Authors:  Li Jiao; Manal M Hassan; Melissa L Bondy; Robert A Wolff; Douglas B Evans; James L Abbruzzese; Donghui Li
Journal:  Am J Gastroenterol       Date:  2007-11-06       Impact factor: 10.864

6.  Inferior vena caval tumor thrombus extending into the right atrium in a patient with pancreatic cancer.

Authors:  Beste Ozben; Nurdan Papila; M Azra Tanrikulu; Fatih Bayalan; Ali Serdar Fak; Ahmet Oktay
Journal:  J Thromb Thrombolysis       Date:  2007-05-05       Impact factor: 2.300

Review 7.  Molecular epidemiology of pancreatic cancer.

Authors:  Donghui Li; Li Jiao
Journal:  Int J Gastrointest Cancer       Date:  2003

8.  The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target.

Authors:  Aude Legoffic; Ezequiel Calvo; Carla Cano; Emma Folch-Puy; Marc Barthet; Jean Robert Delpero; Montse Ferrés-Masó; Jean Charles Dagorn; Daniel Closa; Juan Iovanna
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.